SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC  20549

                                  FORM 12B-25
                                        
                                       Commission File Number      0-23832
                                                              -----------------

                          NOTIFICATION OF LATE FILING
                                        
     (Check One):  [X] Form 10-K   [ ] Form 11-K  [ ] Form 20-F  [ ] Form 10-Q
[ ] Form N-SAR

For Period Ended:    For the Fiscal Year ended April 3, 1998
                     ---------------------------------------

[ ] Transition Report on Form 10-K    [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F    [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K

For the Transition Period Ended:  
                                  -----------------------------

     Read attached instruction sheet before preparing form.  Please print or
type.

     Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

     If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
                                                        ------------------------


                        PART I.  REGISTRANT INFORMATION
                                        
Full name of registrant:    PSS World Medical, Inc.
                            ----------------------------------------------------
Former name if applicable   Physician Sales & Service, Inc.
                            ----------------------------------------------------
Address of principal executive office (Street and number)
                            4345 Southpoint Boulevard
- --------------------------------------------------------------------------------
City, State and Zip Code    Jacksonville, Florida 32216
                            ----------------------------------------------------


                       PART II.  RULE 12B-25 (B) AND (C)
                                        
     If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.  (Check appropriate box.)

[X]  (a)  The reasons described in reasonable detail in Part III of this form
     could not be eliminated without unreasonable effort or expense;

[X]  (b)  The subject annual report, semi-annual report, transition report on
     Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
     before the 15th calendar day following the prescribed due date; or the
     subject quarterly report or transition report on Form 10-Q, or portion
     thereof will be filed on or before the fifth calendar day following the
     prescribed due date; and

[X]  (c)  The accountant's statement or other exhibit required by Rule 12(b)-
     25(c) has been attached if applicable.

 
                             PART III.  NARRATIVE
                                        
     State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-
Q, N-SAR or the transition report portion thereof could not be filed within the
prescribed time period.  (Attach extra sheets if needed.)

     Because the Company consummated a significant merger (Gulf South Medical
     Supply, Inc.) one week prior to the close of the Company's fiscal year,
     which was accounted for as a pooling-of-interests, the Company has
     experienced some delay in assembling financial and other information
     required for its Annual Report on Form 10-K for the fiscal year ended April
     3, 1998.


                          PART IV.  OTHER INFORMATION
                                        
     (1)  Name and telephone number of person to contact in regard to this
notification

David A. Smith (Chief Financial Officer)                  (904) 332-3000
- -------------------------------------------------------------------------------
            (Name)                                (Area code) (Telephone number)

     (2)  Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).
                                                             [X]  Yes  [ ]  No

     (3)  Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
                                                             [ ]  Yes  [X]  No

     If so:  attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.

                            PSS World Medical, Inc.
                 --------------------------------------------
                 (Name of registrant as specified in charter)

Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:  July 1, 1998                    By: /s/ David A. Smith
                                           ------------------
                                           Chief Financial Officer

                                      -2-

 
July 1, 1998


Office of the Chief Accountant
Securities and Exchange Commission
450 Fifth Street, NW
Washington, DC 20549



Dear Sir/Madam:

We have read Item 3 included in the Form 12b-25 dated July 1, 1998 of PSS World
Medical, Inc. to be filed with the Securities and Exchange Commission and are in
agreement with the statements contained therein.

Very truly yours,

ARTHUR ANDERSEN LLP